Kirkus Reviews QR Code
THE VACCINE by Joe Miller

THE VACCINE

Inside the Race To Conquer the Covid-19 Pandemic

by Joe Miller with Özlem Türeci & Uğur Şahin

Pub Date: Feb. 1st, 2022
ISBN: 978-1-250-28036-7
Publisher: St. Martin's

The story of the development of the first effective Covid-19 vaccine.

Readers of Gregory Zuckerman’s excellent A Shot To Save the World learned about the complex mix of unparalleled science, rampant ambition, and fierce competition that led to the creation of a viable vaccine. Miller, the Frankfurt correspondent for the Financial Times who reported on the scientific race, tells a different but equally gripping story that emphasizes aggressive German startup BioNTech, founded by the brilliant husband-and-wife team of Türeci and Şahin. Miller narrates the story, which begins in January 2020 with the workaholic Şahin noting a news story about the emergence of a “novel respiratory illness” in Wuhan, China, that was not yet concerning world epidemiologists. What disturbed him was evidence that healthy people could carry the virus and transmit it, unlike previous (and short-lived) epidemics of SARS and MERS in 2002. Using his experience and calculations, he concluded that it was likely the beginning of a global pandemic. Of course, he was correct, although the World Health Organization didn’t come around until six weeks later. Şahin predicted perhaps 3 million deaths; the number is now over 4 million. At the time, BioNTech concentrated on anti-cancer drugs and was struggling financially. Yet Türeci and Şahin convinced executives (who controlled the money) to change course and devote their entire force to making a vaccine. There follows a vivid, complex (sometimes overly so) description of the frantic 10 months that followed as the company dealt with the political, immunological, technical, statistical, and public relations problems of bringing a radical new vaccine to market in record time. Remarkably, they succeeded. In mass testing of 170 individuals who were infected with Covid-19, only 8 had received the vaccine—a success rate of 95%. Pfizer had worked with BioNTech, especially in the testing and marketing approval process, so many Americans know it as the Pfizer vaccine, but it was conceived in Germany by two Turkish-born scientists.

A fine account of a medical tour de force.